BMY Analyst Forecast: Expert Predictions and Future Outlook

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date
05/16/2024	Cowen & Co.	Steve Scala	$67.00	$44.11	51.89%
01/30/2024	Deutsche Bank	James Shin	$55.00	$49.87	10.29%
11/27/2023	BMO Capital	Evan Seigerman	$60.00	$49.76	20.58%
10/12/2023	Leerink Partners	David Risinger	$66.00	$56.25	17.34%
09/06/2023	Cantor Fitzgerald	Louise Chen	$75.00	$59.67	25.69%
05/18/2022	Wells Fargo	Mohit Bansal	$70.00	$78.22	-10.51%
05/02/2022	Guggenheim	Seamus Fernandez	$80.00	$75.27	6.28%
05/01/2022	BMO Capital	Evan Seigerman	$87.00	$75.08	15.88%
04/10/2022	Morgan Stanley	Terence Flynn	$64.00	$76.50	-16.34%
04/03/2022	BMO Capital	Evan Seigerman	$81.00	$73.79	9.77%
03/27/2022	Morgan Stanley	Matthew Harrison	$66.00	$73.11	-9.73%
03/16/2022	BMO Capital	Evan David Seigerman	$74.00	$70.52	4.93%
10/27/2021	Barclays	Carter Gould	$66.00	$56.22	17.4%
10/24/2021	Citigroup	Andrew Baum	$75.00	$56.89	31.83%
09/19/2021	Guggenheim	Seamus Fernandez	$82.00	$59.05	38.87%
09/06/2021	Societe Generale	Justin Smith	$85.00	$63.63	33.58%
07/26/2021	Bank of America Securities	Geoff Meacham	$78.00	$65.88	18.4%

Q. What analysts cover Bristol-Myers Squibb Company?

A. Bristol-Myers Squibb Company has been rated by research analysts at Cowen & Co., Deutsche Bank, BMO Capital, Leerink Partners, Cantor Fitzgerald, Wells Fargo in the past 90 days.